SBI Healthcare Opportunities Fund · Regular · Growth
NAV
₹513.3045
as of 31 Jul 2026
Expense Ratio
1.93%
AUM
₹4,319 Cr
Lumpsum returns (CAGR)
- 1Y
- +16.28%
- 3Y
- +23.12%
- 5Y
- +16.97%
- Since Inception
- +15.69%
SIP returns (XIRR)
- 1Y
- +32.75%
- 3Y
- +21.33%
- 5Y
- +22.11%
- Since Inception
- +16.61%
What history actually did — last 10 years (Aug 2016 – Jul 2026)
A ₹5,000 monthly SIP for the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹16,47,125 today — ₹5,95,000 invested, 19.6% XIRR.
₹5,95,000
Invested
₹16,47,125
Value today
19.6%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,57,930 today (13.6% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2016 would still hold ₹19,32,178.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹16,47,125 in this fund vs ₹12,17,407 in the benchmark — outperformance of ₹4,29,718.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Aug 2016 – Jul 2026) (22 Mar 2020) would be ₹4,99,416 today (4.99×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.85
Sharpe Ratio
+0.17
Alpha
0.18
Beta
0.83
Sortino
13.20%
Std Dev
-9.63%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology63.92%
- Healthcare Services26.05%
- Chemicals & Petrochemicals5.03%
- Healthcare Equipment & Supplies2.16%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.11.18%
- 2Acutaas Chemicals Ltd.6.35%
- 3Divi'S Laboratories Ltd.5.92%
- 4Apollo Hospitals Enterprise Ltd.5.21%
- 5Max Healthcare Institute Ltd.5.08%
- 6Aurobindo Pharma Ltd.4.17%
- 7Aster Dm Healthcare Ltd.3.77%
- 8Laurus Labs Ltd.3.64%
- 9Cipla Ltd.3.52%
- 10Torrent Pharmaceuticals Ltd.3.33%
Investment Objective
SBI Healthcare Opportunities Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 27 years. It manages assets worth ₹4,319 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TRI. The current expense ratio is 1.93%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations